Linden Thomas Advisory Services’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Linden Thomas Advisory Services's DGX Position: Q3 2026 in Review
Linden Thomas Advisory Services increased its Quest Diagnostics (DGX) stake by 36% in Q3 2026, buying an estimated $1.05M and bringing the position to 17,102 shares worth $3.99M. The position accounts for 0.32% of the portfolio, ranked #81.
Linden Thomas Advisory Services first reported a position in DGX in Q4 2022 and has held it in 16 quarters since. 530 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Linden Thomas Advisory Services held 17,102 shares of Quest Diagnostics worth $3.99M as of Q3 2026.
- Linden Thomas Advisory Services bought 4,563 Quest Diagnostics shares in Q3 2026, an estimated $1.05M.
- Quest Diagnostics made up 0.32% of Linden Thomas Advisory Services's portfolio in Q3 2026, its #81 holding.
- Linden Thomas Advisory Services first reported a position in Quest Diagnostics in Q4 2022 and has held it in 16 quarters since.
- 530 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Linden Thomas Advisory Services's 13F filing for Q3 2026, filed 19 Oct 2026.